Select Ongoing Trials Currently Enrolling Patients with Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 27
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 4
Results: 13
1
2
Using the 5 Whys Method to Identify and Solve Problems.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 24
- By:
- Publication type:
- Article
3
Covid Lessons From Bush's Effort Against AIDS: Pressured to break drug patents in 2004, he came up with a better plan, an example for Biden.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 23
- By:
- Publication type:
- Article
4
Watch Out for a Vaccine Patent Heist: The left wants Biden to force drug companies to give away their IP.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 22
- Publication type:
- Article
5
Zanidatamab Demonstrates Durable Antitumor Activity in HER2-Overexpressing Gastric Cancers.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 20
- By:
- Publication type:
- Article
6
Ivosidenib Extends Survival in Patients with Cholangiocarcinoma and IDH1 Mutation.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 18
- By:
- Publication type:
- Article
7
Enfortumab Vedotin Prolongs Survival in Patients with Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 16
- By:
- Publication type:
- Article
8
<sup>177</sup>Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 15
- By:
- Publication type:
- Article
9
Some Postmenopausal Women with Early-Stage HR-Positive, HER2-Negative Breast Cancer May Be Able to Skip Additional Chemotherapy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 11
- By:
- Publication type:
- Article
10
Abemaciclib plus Endocrine Therapy Offers Invasive Disease--Free Survival Benefit in Patients with High-Risk, HR-Positive, Early-Stage Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 9
- By:
- Publication type:
- Article
11
Nivolumab plus Cabozantinib Prolongs Survival in Advanced Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 1
- By:
- Publication type:
- Article
12
Pembrolizumab plus Chemotherapy Combo Improves Progression- Free Survival in Metastatic TNBC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 1
- By:
- Publication type:
- Article
13
Will Amazon Care Disrupt Oncology Care?
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 1
- By:
- Publication type:
- Article